Department of Radiology

Publications

2019

Cousin SF, Liberman G, Solomon E, Otikovs M, Frydman L. A regularized reconstruction pipeline for high-definition diffusion MRI in challenging regions incorporating a per-shot image correction. Magn Reson Med. 2019;82(4):1322-1330.

Dimov A, Patel W, Yao Y, Wang Y, O'Halloran R, Kopell BH. Iron concentration linked to structural connectivity in the subthalamic nucleus: implications for deep brain stimulation. J Neurosurg. 2019:1-8.

Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, et al. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. 2019;92(11):519-533.

Zhuang M, Karakatsanis NA, Dierckx RA, Zaidi H. Impact of Tissue Classification in MRI-Guided Attenuation Correction on Whole-Body Patlak PET/MRI. Mol Imaging Biol. 2019;21(6):1147-1156.

Pan W, Wallin TJ, Odent J, Yip MC, Mosadegh B, Shepherd RF, et al. Optical stereolithography of antifouling zwitterionic hydrogels. J Mater Chem B. 2019;7(17):2855-2864.

Spincemaille P, Liu Z, Zhang S, Kovanlikaya I, Ippoliti M, Makowski M, et al. Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness. J Neuroimaging. 2019;29(6):689-698.

Gazes Y, Li P, Sun E, Razlighi Q, Tsapanou A. Age specificity in fornix-to-hippocampus association. Brain Imaging Behav. 2019;13(5):1444-1452.

Azuma M, Hirai T, Nakaura T, Kitajima M, Yamashita S, Hashimoto M, et al. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease. J Neurol Sci. 2019;406:116443.

Kuceyeski AF, Jamison KW, Owen JP, Raj A, Mukherjee P. Longitudinal increases in structural connectome segregation and functional connectome integration are associated with better recovery after mild TBI. Hum Brain Mapp. 2019;40(15):4441-4456.

Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, et al. Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. Sci Rep. 2019;9(1):10634.